• Login
    • Join
  • FOLLOW:
  • Subscribe Free
    • Magazine
    • eNewsletter
    Checkout
    • Magazine
    • News
    • Manufacturing
    • Packaging
    • Development
    • Compliance
    • Top 20
    • Directory
    • Solution Center
    • Events
    • More
  • Magazine
  • News
  • Manufacturing
  • Packaging
  • Development
  • Compliance
  • Top 20
  • Directory
  • Solution Center
  • Events
  • Current / Back Issue
    Features
    Editorial
    Columns
    Digital Edition
    eNewsletter Archive
    Our Team
    Editorial Guidelines
    Subscribe Now
    Advertise Now
    Top Features
    Pharma Supply Chains: From Fragile to Agile

    Advanced Manufacturing and a Roadmap to the Facility of the Future

    Solving Pharma’s Underlying Rebate Leakage Problem

    Pharmaceutical Labeling: Overcoming Regulatory & Operational Challenges

    Revolutionizing Pharma’s Supply Chain
    Breaking News
    Online Exclusives
    Industry News
    Collaborations & Alliances
    Promotions & Moves
    Trials & Filings
    Financial Reports
    Bio News & Views
    Custom Sourcing News
    Packaging & Tracking
    CRO News
    Live From Shows
    Top News
    Univercells Expands into the U.S. With New Offices in Andover, MA

    Evecxia Therapeutics, Quotient Sciences Complete Phase I Clinical Milestone for New Depression Treat

    Sanner Group Opens Second Manufacturing Facility in China

    Körber Integrates Werum PAS-X MES with Bausch+Ströbel Systems

    Merck KGaA, Quris-AI Expand Collaboration
    APIs
    Aseptic Processing
    Cleaning Validation
    Clinical Trial Materials
    Cytotoxics and High Potency Manufacturing
    Equipment
    Excipients
    Extractables and Leachables
    Facilities
    Fill/Finish
    Lyophilization
    Parenterals
    Process Development
    Process Validation
    Risk Management
    Scale-up/ Technology Transfer
    Solid Dosage/ Creams/ Ointments

    Univercells Expands into the U.S. With New Offices in Andover, MA

    Evecxia Therapeutics, Quotient Sciences Complete Phase I Clinical Milestone for New Depression Treat

    Sanner Group Opens Second Manufacturing Facility in China

    Körber Integrates Werum PAS-X MES with Bausch+Ströbel Systems

    "3 Key Trends" with Srinivasan Shanmugam
    Capsules
    Cold Chain Management
    Injectables
    Logistics
    Serialization
    Solid Dosage / Semi-solids
    Supply Chain
    Vials

    Pharmaceutical Continuous Manufacturing: USP Technical Guide

    Mikart Expands Production and Packaging Capabilities

    Flavor Masking for Rx and OTC Drugs

    Prefilled Syringe Production: Filling a Need with Modern Equipment

    Making the Complex, Simple: A Roadmap for Your OSD Journey
    Analytical Services
    Bioanalytical Services
    Bioassay Developement
    Biologics, Proteins, Vaccines
    Biosimilars
    Chemistry
    Clinical Trials
    Drug Delivery
    Drug Development
    Drug Discovery
    Formulation Development
    Information Technology
    Laboratory Testing
    Methods Development
    Microbiology
    Preclinical Outsourcing
    R&D
    Toxicology

    Evecxia Therapeutics, Quotient Sciences Complete Phase I Clinical Milestone for New Depression Treat

    Merck KGaA, Quris-AI Expand Collaboration

    BioCity, AstraZeneca Partner on Treatment of Advanced HCC

    Sartorius, SPARTA Biodiscovery Partner on Nanoparticle Analysis Platform

    Peptone Expands Leadership Team with Key Executive Hires
    Filtration & Purification
    GMPs/GCPs
    Inspections
    QA/QC
    Regulatory Affairs
    Validation

    Pharmaceutical Labeling: Overcoming Regulatory & Operational Challenges

    Rentschler Biopharma’s ATMP UK Facility Receives MHRA Approval

    Aurisco's Manufacturing Site in China Clears FDA Inspection

    LighthouseAI Secures $2.25M Investment to Grow Supply Chain Products

    Valisure, DoD Conduct Pharmaceutical Quality Risk Assessment Study
    Companies
    Categories
    Corporate Capabilities
    Add New Company
    Contract Service Directory Companies
    AMERIPHARMA

    U.S. Pharmacopeia (USP)

    TaiMed Biologics

    Societal CDMO

    CMC Pharmaceuticals
    Companies
    News Releases
    Posters
    Brochures
    Services
    Videos
    Case Study
    White Papers
    Jobs
    Contract Service Directory Companies
    AMERIPHARMA

    U.S. Pharmacopeia (USP)

    TaiMed Biologics

    Societal CDMO

    CMC Pharmaceuticals
    Webinars
    Live From Shows
    • Magazine
      • Current / Back Issue
      • Features
      • Editorial
      • Columns
      • Editorial Guidelines
      • Subscribe Now
      • Advertise Now
      • Enewsletter Archive
      • Digital Edition
    • Directory
      • Companies
      • Categories
      • Corporate Capabilities
      • Add Your Company
    • Manufacturing
      • APIs
      • Aseptic Processing
      • Cleaning Validation
      • Clinical Trial Materials
      • Cytotoxics and High Potency Manufacturing
      • Equipment
      • Excipients
      • Extractables and Leachables
      • Facilities
      • Fill/Finish
      • Lyophilization
      • Parenterals
      • Process Development
      • Process Validation
      • Risk Management
      • Scale-up/ Technology Transfer
      • Solid Dosage/ Creams/ Ointments
      • cGMP Manufacture
    • Packaging
      • Capsules
      • Cold Chain Management
      • Injectables
      • Logistics
      • Serialization
      • Solid Dosage / Semi-solids
      • Supply Chain
      • Vials
    • Development
      • Analytical Services
      • Bioanalytical Services
      • Bioassay Developement
      • Biologics, Proteins, Vaccines
      • Biosimilars
      • Chemistry
      • Clinical Trials
      • Drug Delivery
      • Drug Development
      • Drug Discovery
      • Formulation Development
      • Information Technology
      • Laboratory Testing
      • Methods Development
      • Microbiology
      • Preclinical Outsourcing
      • R&D
      • Toxicology
    • Compliance
      • Filtration & Purification
      • GMPs/GCPs
      • Inspections
      • QA/QC
      • Regulatory Affairs
      • Validation
    • Top 25 Pharma & BioPharma
    • Contract Pharma Direct
    • Breaking News
    • Online Exclusives
    • Slideshows
    • Experts Opinions
    • Surveys
      • Outsourcing Survey
      • Salary Survey
    • Glossary
    • Videos
    • White Papers
    • Podcasts
    • Infographics
    • Microsites
      • Companies
      • News Releases
      • Posters
      • Brochures
      • Services
      • Videos
      • Case Study
      • White Papers
    • Contract Pharma Conference
      • Contract Pharma Conference
      • Speakers
      • Exhibitors
      • Conference Sessions
    • eBook
    • Webinars
    • Events
      • Industry Events
      • Live from Show Events
      • Webinars
    • Classifieds / Job Bank
      • Classifieds
      • Job Bank
    • About Us
      • About Us
      • Contact Us
      • Advertise With Us
      • Privacy Policy
      • Terms of Use
    Expert's Opinion

    Five Digital Trends Transforming the Life Sciences Industry

    Putting patients at the heart of innovation

    Five Digital Trends Transforming the Life Sciences Industry
    12.05.17
    The life sciences industry is on the brink of radical reinvention, driven by extraordinary advances in science combined with widespread access to data, cloud capabilities and other digital technologies. Life sciences companies today are creating more relevant products and services than ever before, enriching human lives and empowering patients to play a more active role in their health.

    Each of the five trends we explored in our 2017 Tech Vision for Life Sciences report, AI is the New UI, Ecosystem Power Plays, Workforce Marketplace, Design for Humans, and The Uncharted, is rooted in the changing relationship between humans and technology. Whether by leveraging AI to empower employees or implementing human-centric design principles, companies that put people at the heart of innovation will see big returns in the years to come.

    But understanding what these trends mean for the industry at large is only part of the story. How can individual life sciences organizations leverage these insights to drive meaningful results for stakeholders and the business?

    AI is the New UI
    In the past, artificial intelligence (AI) functioned exclusively as a backend capability, helping life sciences companies to become more efficient and to accelerate the development and delivery of new products and services. Today, AI has taken on a more nuanced, sophisticated role within these same organizations, allowing for more seamless customer and patient interactions. Our report revealed that 74 percent of life sciences executives believe AI will significantly impact the industry.

    To harness the full potential of artificial intelligence, life sciences organizations should start by identifying their main business priorities, such as cost savings, heightened communication or better customer insights. Any artificial intelligence initiatives should track back directly to these goals. Not only will this be useful in securing stakeholder support, it will also allow business leaders to more easily measure impact. Similarly, instead of taking a “technology for technologies sake” approach to AI adoption, organizations should develop use cases around specific user journeys to help demonstrate in a tangible, methodical way how the technology will allow the business to achieve its goals.

    Ecosystem Power Plays
    The age of the insular life sciences organization is over. Today, collaboration is a key indicator of success across the entire healthcare ecosystem, allowing organizations to rapidly define, develop, supply and commercialize new products and solutions. At the heart of this transformation are platform-based digital ecosystems, which come in three primary configurations: platforms that aggregate data from various organizations to help accelerate innovation and discovery; patient services platforms that help life sciences companies transition from volume to value based business models; and platforms that support IoT integration.

    As with artificial intelligence, it is crucial that life sciences companies align their adoption of platform-based models with desired business outcomes. Before implementing new IT and application architecture, companies should assess opportunities to replace legacy systems with platforms and ecosystems, as well as the skillsets required to effectively support these new technologies. Furthermore, to increase visibility into new innovations in digital health, they should consider joining start-up initiatives or investing in new, health technology innovation venturing capabilities.

    Workforce Marketplace
    The face of work is rapidly changing. According to a recent study by LinkedIn, freelancers will represent 43 percent of the workforce by 2020. This shift toward more fluid work arrangements has coincided with a rise in flexible workforce solutions such as on-demand labor platforms and online work management tools. For healthcare and life sciences organizations, these solutions offer the flexibility and agility needed to innovate and stay competitive.

    For many life science companies, outsourcing may be business-as-usual. This is especially true in the digital era, where organizations frequently supplement their workforce in non-core competency areas like cybersecurity, advanced analytics or IoT.  But for companies interested in expanding their footprint in the workforce marketplace, a good first step is to determine how and when the business leverages external talent. Perhaps there are certain departments where work is highly variable, cost sensitive or driven in large part by specialist skills? If so, this could be an opportunity to pilot a larger initiative, sharing findings with stakeholders upon conclusion.

    Another important step when joining the workforce marketplace is to define and implement the policies, governance and technology needed to operate in this new space.  With formal structures in place, the business will be better positioned to integrate sourcing strategies to ensure that all parties – both internal and external – can collaborate as seamlessly and effectively as possible. As part of this process, companies should look for opportunities to increase efficiency and lower costs by leveraging automated workforces, such as bots, artificial intelligence and machine learning.  This will allow them to redirect resources – both human and financial – to other areas of the business.

    Design for Humans
    We’re currently living in the era of patient empowerment, in which technologies are giving individuals unprecedented control over their health. For a product or solution to be a commercial success today, it must cater to human needs and expectations. Over 78 percent of executives surveyed for Accenture’s Technology Vision for Life Sciences report agree that understanding the customer experience and creating solutions and services that align with human behavior will be a competitive differentiator for their organization.

    So how can organizations embrace a more human-centric model? A good first step is to evaluate what existing solutions or processes could be reconfigured to provide a more personalized, patient-centric experience. There’s also an important cultural component to human-centric design. From the c-suite down, individuals at every level of the organization must strive to prioritize the needs of patients and customers and look for new ways to evolve their market approach. When it comes to new products or services, development teams must identify the ideal outcome for the end-user they’re trying to reach and work toward achieving that goal.

    The Uncharted
    Technology is ushering in a new era of innovation for healthcare and life sciences, creating new opportunities and challenges – particularly from a regulatory perspective. Combined with an industry-wide shift from volume to value, this disruption is forcing many companies into uncharted territory. According to Accenture research, 74 percent of life sciences executives believe they are entering entirely new digital industries and regulatory grey areas.

    To capitalize on the potential of this new environment, life sciences companies should look for ways to engage the start-up community, establishing their reputation as a resource, mentor, or potential partner. Of course, they can’t just talk the talk – they must also walk the walk. To that end, companies should take steps to create an innovation-friendly culture, designating “Innovation Stewards” on internal teams that can help encourage out-of-the-box thinking. Establishing innovation goals and incentives will also motivate individuals and teams to be more creative. Training is also important, so employees can understand and apply innovative methodologies in their work. And since collaboration is a key ingredient to innovation, organizations should look for potential partners within the broader healthcare ecosystem to test promising ideas and develop prototypes.

    The time to act is now. Rather than fighting disruption, life science organizations must seize the opportunity to create better, more relevant products and solutions that empower patients and customers. By taking advantage of the five trends outlined in our report, organizations will emerge as leaders in the people-first digital future. 
     


     
    Brags Srinivasan is managing director and global lead for Accenture’s Life Sciences Technology practice. He has more than 22 years of experience in the IT industry with extensive proficiency managing and delivering complex system integration programs and large-scale application services engagements for numerous clients, particularly in life sciences.
    Related Searches
    • analytics
    • study
    • training
    • Outsourcing
    Suggested For You
    Lonza Breaks Ground on Commercial Drug Product Facility in Stein Lonza Breaks Ground on Commercial Drug Product Facility in Stein
    pHOXBIO Unveils Trial Results from COVID Prophylactic Nasal Spray pHOXBIO Unveils Trial Results from COVID Prophylactic Nasal Spray
    Rentschler Biopharma Appoints Dr. Christian Schetter as Chief Scientific Officer Rentschler Biopharma Appoints Dr. Christian Schetter as Chief Scientific Officer
    CEO Spotlight: Gaston Salinas, Botanical Solution Inc. CEO Spotlight: Gaston Salinas, Botanical Solution Inc.
    Aurion Biotech Makes Strategic Investments in Manufacturing Aurion Biotech Makes Strategic Investments in Manufacturing
    Lakes BioScience Signs Agreement with Cytvia Lakes BioScience Signs Agreement with Cytvia
    Tekni-Plex Names Chris Qualters as CEO of Healthcare Division Tekni-Plex Names Chris Qualters as CEO of Healthcare Division
    Repligen and Navigo Launch Antibody Technology Platform Repligen and Navigo Launch Antibody Technology Platform
    Newsmakers: Gaston Salinas, Botanical Solution Inc. Newsmakers: Gaston Salinas, Botanical Solution Inc.
    Cytiva Triples Single-Use Consumables Capacity in China Cytiva Triples Single-Use Consumables Capacity in China
    CRB, Umoja Biopharma Begin Construction at Development and Manufacturing Site CRB, Umoja Biopharma Begin Construction at Development and Manufacturing Site
    Avantor Commences Multi-Year Investment in Global Hydration Capabilities Avantor Commences Multi-Year Investment in Global Hydration Capabilities
    Cryoport and Mitsubishi Logistics Corporation Partner Cryoport and Mitsubishi Logistics Corporation Partner
    Modularity in Injectables Manufacturing Modularity in Injectables Manufacturing
    Sai Life Sciences Opens New Biology Facility in Hyperbad, India Sai Life Sciences Opens New Biology Facility in Hyperbad, India

    Related Breaking News

    • Breaking News | Facilities | Industry News
      Lonza Breaks Ground on Commercial Drug Product Facility in Stein

      Lonza Breaks Ground on Commercial Drug Product Facility in Stein

      Milestone for the development of Lonza’s first large-scale drug product manufacturing facility based in Stein.
      02.01.23

    • Breaking News | Clinical Trials
      pHOXBIO Unveils Trial Results from COVID Prophylactic Nasal Spray

      pHOXBIO Unveils Trial Results from COVID Prophylactic Nasal Spray

      According to the study, the novel prophylactic nasal spray prevented infection from SARS-CoV-2, the virus that causes COVID-19.
      09.22.21

    • Breaking News | Promotions & Moves
      Rentschler Biopharma Appoints Dr. Christian Schetter as Chief Scientific Officer

      Rentschler Biopharma Appoints Dr. Christian Schetter as Chief Scientific Officer

      Schetter has a proven track record across the entire biopharmaceutical value chain.
      09.20.21


    • Biologics, Proteins, Vaccines
      CEO Spotlight: Gaston Salinas, Botanical Solution Inc.

      CEO Spotlight: Gaston Salinas, Botanical Solution Inc.

      QS-21 has become the ‘Gold Standard’ for human vaccine adjuvants and BSI is positioned to become a reliable supplier to the pharmaceutical market.
      Tim Wright, Editor, Contract Pharma 09.14.21

    • Breaking News | Industry News | Promotions & Moves
      Aurion Biotech Makes Strategic Investments in Manufacturing

      Aurion Biotech Makes Strategic Investments in Manufacturing

      Appoints Tim Largen as VP of manufacturing to drive cell therapy production strategy and direct collaborations with leading CDMOs.
      09.14.21

    Loading, Please Wait..
    Breaking News
    • Univercells Expands into the U.S. With New Offices in Andover, MA
    • Evecxia Therapeutics, Quotient Sciences Complete Phase I Clinical Milestone for New Depression Treat
    • Sanner Group Opens Second Manufacturing Facility in China
    • Körber Integrates Werum PAS-X MES with Bausch+Ströbel Systems
    • Merck KGaA, Quris-AI Expand Collaboration
    View Breaking News >
    CURRENT ISSUE

    September 2023

    • Pharma Supply Chains: From Fragile to Agile
    • Overcoming Stressors in Knowledge Transfer
    • Innovations in Pharma Packaging
    • HPAPI Manufacturing Trends
    • Sustainable Packaging in Pharma: No Longer a Pipe Dream
    • Revolutionizing Pharma’s Supply Chain
    • Pharmaceutical Labeling: Overcoming Regulatory & Operational Challenges
    • Solving Pharma’s Underlying Rebate Leakage Problem
    • Advanced Manufacturing and a Roadmap to the Facility of the Future
    • View More >

    Cookies help us to provide you with an excellent service. By using our website, you declare yourself in agreement with our use of cookies.
    You can obtain detailed information about the use of cookies on our website by clicking on "More information”.

    • About Us
    • Privacy Policy
    • Terms And Conditions
    • Contact Us

    follow us

    Subscribe
    Nutraceuticals World

    Latest Breaking News From Nutraceuticals World

    PLT Health Solutions Granted Claims for Botanical Ingredient in Canada
    CRN Files Petition with FTC For Clarity on Health Products Compliance Guidance
    Vitafoods Europe Relocates to Barcelona Starting 2025
    Coatings World

    Latest Breaking News From Coatings World

    California Sports Surfaces Celebrates 70 Years
    ROSS Offers Cost-Effective, Expertly Reconditioned Equipment
    AkzoNobel Shares Sustainable Architectural Solutions at Conference
    Medical Product Outsourcing

    Latest Breaking News From Medical Product Outsourcing

    SeaStar Medical Gets Breakthrough Nod for Selective Cytopheretic Device
    ResMed, Nyxoah Team Up to Grow Sleep Apnea Awareness & Therapy in Germany
    Siemens Healthineers’ Magnetom Viato.Mobile Cleared by FDA
    Contract Pharma

    Latest Breaking News From Contract Pharma

    Univercells Expands into the U.S. With New Offices in Andover, MA
    Evecxia Therapeutics, Quotient Sciences Complete Phase I Clinical Milestone for New Depression Treat
    Sanner Group Opens Second Manufacturing Facility in China
    Beauty Packaging

    Latest Breaking News From Beauty Packaging

    YSL Beauty Taps Finn Wolfhard, Lil Yachty & More for Fragrance Campaign
    74% of Makeup Users Open to Affordable ‘Dupes,’ Mintel Says
    Stoelzle Glass Group Names New CEO
    Happi

    Latest Breaking News From Happi

    Breakfast with Oral Care Benefits?
    Stanford Researchers Study Skin and Sensorial Perception
    L’Oréal Awarded US Patent for Makeup
    Ink World

    Latest Breaking News From Ink World

    Siegwerk’s Climate Targets Validated by SBTi
    ROSS Offering Cost-Effective, Expertly Reconditioned Equipment
    Amcor plc Adds Lucrèce Foufopoulos-De Ridder to Board of Directors
    Label & Narrow Web

    Latest Breaking News From Label & Narrow Web

    SABIC and partners launch bio-based IML solution for food packaging
    tesa completes expansion of Michigan manufacturing facility
    Comexi and Asahi to host 'Effortless Platemaking' event
    Nonwovens Industry

    Latest Breaking News From Nonwovens Industry

    Greentech Introduces Air Filter with Advanced Odor Elimination
    Ontex Divests Pakistan Operations to ASAIA Holding
    Goodnites Bedwetting Underwear Recognized by Good Housekeeping
    Orthopedic Design & Technology

    Latest Breaking News From Orthopedic Design & Technology

    ChitogenX Granted New U.S., Canadian ORTHO-R Patent
    Centinel Spine prodisc System Surpasses 2,500-Implant Milestone
    Medacta Completes First U.S. MyPAO Hip Surgery
    Printed Electronics Now

    Latest Breaking News From Printed Electronics Now

    Jabil Posts Fourth Quarter, Fiscal Year 2023 Results
    Ink-Borne ‘Chiplets’ Could Lead to Printable Displays, Electronics and More
    SCHOTT Strengthens Glass Substrate Portfolio

    Copyright © 2023 Rodman Media. All rights reserved. Use of this constitutes acceptance of our privacy policy The material on this site may not be reproduced, distributed, transmitted, or otherwise used, except with the prior written permission of Rodman Media.

    AD BLOCKER DETECTED

    Our website is made possible by displaying online advertisements to our visitors.
    Please consider supporting us by disabling your ad blocker.


    FREE SUBSCRIPTION Already a subscriber? Login